Clinical Research Directory
Browse clinical research sites, groups, and studies.
GammaPod Registry and Quality of Life Nomogram
Sponsor: University of Maryland, Baltimore
Summary
This study is a prospective, single arm study (registry) summarizing patient-level adverse-event and tumor outcomes as well as a number of feasibility and dosimetric characteristics of delivering a single-fraction boost with the GammaPod.
Official title: Tumor Bed Boost Using a Breast Specific Radiosurgery Device, The GammaPodTM: Registry Study and Evaluation of Quality of Life With Development of Sizing Nomogram
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
160
Start Date
2019-01-03
Completion Date
2030-12
Last Updated
2026-02-20
Healthy Volunteers
No
Conditions
Interventions
Quality Of Life Sizing Nomogram
If the participant meets the eligibility criteria of the study, and participant chooses to take part, they will receive the tumor bed boost in 8 Gy in 1 fraction just prior to starting whole breast radiation after joining the study. Treatment to the whole breast will begin within 7-8 days from the TB boost (GammaPodTM) treatment. The radiation therapy will take approximately 6 weeks to complete. Follow-up visits specifically for this study will continue for one year, although the physician will continue to follow as part of routine care.
Locations (4)
Upper Chesapeake Health
Bel Air, Maryland, United States
Central Maryland Oncology Center
Columbia, Maryland, United States
Baltimore Washington Medical Center
Glen Burnie, Maryland, United States
UTSouthwestern
Dallas, Texas, United States